Latest From This Author
From banks to tech firms to Hollywood studios, corporate executives vowed Friday to do what they could to help their employees continue to access abortion after the Supreme Court threw out 49 years of precedent.
-
The alleged scheme capitalized on federal laws that were meant to smooth the way for people to get tested without fretting about the bill, according to complaints filed by L.A. authorities.
-
Oxitec says its genetically modified bugs could help control invasive populations of the Aedes aegypti mosquito, which can spread diseases. Some scientists worry releasing the creatures into the wild may have more risk than benefit.
-
Los reguladores federales aprueban cada vez más medicamentos antes de que los estudios demuestren que son eficaces, lo que hace que los pacientes corran el riesgo de tomar recetas que podrían perjudicarles en lugar de ayudarles.
-
Federal regulators are increasingly approving medicines before studies have shown they work, leaving patients at risk of taking prescriptions that could harm but not help them.
-
Un estudio reveló que el medicamento Makena no reduce el riesgo de parto prematuro, y la FDA recomendó su retirada del mercado. Su fabricante se ha negado.
-
The drug Makena doesn’t reduce the risk of preterm birth, a study found, and the FDA recommended it be taken off the market. Its maker has refused.
-
Innova Medical Group, de Pasadena, ha recaudado más de 2.700 millones de dólares importando pruebas de antígenos de China y exportándolas a Reino Unido, a pesar de las dudas sobre su precisión.
-
Innova Medical Group in Pasadena secured contracts worth at least $2.7 billion selling Chinese-made antigen tests to the U.K. government despite questions over their accuracy.
-
Federal regulators revoked the authorization of a COVID-19 test given to millions of people across the country, including hundreds of thousands at Dodger Stadium.
